Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| E968 SCHEMBL578415 | 0.92 | ALDH1A1 (0.43) | ALDH1A1LMNAL3MBTL1TDP1TSHR | |
| SCHEMBL8969951 | 0.86 | — | — | |
| SCHEMBL284499 | 0.86 | — | — | |
| SCHEMBL19442103 | 0.86 | — | — | |
| SCHEMBL352393 | 0.86 | — | — | |
| Water SCHEMBL27508588 | 0.83 | — | — | |
| SCHEMBL27470459 | 0.83 | — | — | |
| E968 SCHEMBL3916788 | 0.82 | USP2 (0.42) | ALDH1A1LMNAL3MBTL1TDP1TSHR | |
| Ribitol SCHEMBL3904172 | 0.81 | LMNA (0.53) | ALDH1A1LMNAL3MBTL1TDP1KDM4E | |
| Xylitol SCHEMBL20561020 | 0.81 | LMNA (0.53) | ALDH1A1LMNAL3MBTL1TDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559586-B2 | Compositions containing uretdione groups crosslinking at low temperatures | COVESTRO DEUTSCHLAND AG (DE) | 2026-02-24 | — | — | US | disclosed |
| EP-3959251-B1 | LATENT REACTIVE ADHESIVE PREPARATIONS | COVESTRO DEUTSCHLAND AG (DE) | 2024-03-27 | — | — | EP | disclosed |
| CN-112189153-B | Near infrared ray absorbing composition, near infrared ray absorbing film, and image sensor for solid-state imaging element | 柯尼卡美能达株式会社 | 2023-11-21 | — | — | CN | disclosed |
| EP-3997183-B1 | METHOD FOR THE PRODUCTION OF ISOCYANURATES FROM URETDIONES | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2023-10-04 | — | — | EP | disclosed |
| US-20230192941-A1 | COMPOSITIONS CONTAINING URETDIONE GROUPS CROSSLINKING AT LOW TEMPERATURES | COVESTRO DEUTSCHLAND AG (DE) | 2023-06-22 | — | — | US | disclosed |
| CN-115605525-A | Uretdione group-containing compositions which crosslink at low temperatures | 科思创德国股份有限公司（DE） | 2023-01-13 | — | — | CN | disclosed |
| US-20220348708-A1 | METHOD FOR PRODUCING ISOCYANURATES FROM URETDIONES | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2022-11-03 | — | — | US | disclosed |
| US-20220251280-A1 | PROCESS OF PREPARING ALLOPHANATE- AND/OR THIOALLOPHANATE GROUP-CONTAINING COMPOUNDS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2022-08-11 | — | — | US | disclosed |
| EP-4029892-A1 | COMPOSITIONS CONTAINING URETDIONE GROUPS | Covestro Deutschland AG (DE) | 2022-07-20 | — | — | EP | disclosed |
| US-20220177751-A1 | LATENT REACTIVE ADHESIVE PREPARATIONS | COVESTRO DEUTSCHLAND AG (DE) | 2022-06-09 | — | — | US | disclosed |
| US-6051634-A | MAKING A HIGH STRENGTH MINERAL BUILDING MATERIAL BY MIXING A POLYETHERURETHANE HAVING SPECIFIC CONTENT OF ETHYLENE OXIDE UNITS, URETHANE GROUPS AND ISOCYANATE FUNCTIONALITY WITH AN AGGREGATE, HYDRAULIC ORGANIC BINDER AND WATER; HARDENING | BAYER AKTIENGESELLSCHAFT (DE) | 2000-04-18 | — | — | US | disclosed |
| EP-0270690-B1 | DRUG FOR TREATMENT AND PROPHYLAXIS OF KIDNEY AND LIVER DISEASES | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1991-05-15 | — | — | EP | disclosed |
| US-4898890-A | ADMINISTERING ISOLIQUIRITIGENIN | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1990-02-06 | — | — | US | disclosed |
| EP-0270690-A1 | DRUG FOR TREATMENT AND PROPHYLAXIS OF KIDNEY AND LIVER DISEASES | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1988-06-15 | — | — | EP | disclosed |
| US-4552865-A | CAERULEIN, SCHIZOPHRENIA | SHIONOGI & CO., LTD. (JP) | 1985-11-12 | — | — | US | disclosed |
| US-4500321-A | FILTRATION, MIXING WITH ORGANIC SOLVENT | CIBA-GEIGY CORPORATION (US) | 1985-02-19 | — | — | US | disclosed |
| US-4466900-A | Process for the preparation of fluorescent brightener formulations which are stable on storage | CIBA-GEIGY CORPORATION (US) | 1984-08-21 | — | — | US | disclosed |
| US-4405329-A | WATER OR SOLVENT SOLUTIONS OF MONO-OR POLYAZO OR ANTRAQUINONE DYES AND NONIONIC SURFACTANT; LEATHER; PAPER; TEXTILES | CIBA-GEIGY CORPORATION (US) | 1983-09-20 | — | — | US | disclosed |
| US-4322415-A | Stable concentrated liquid preparations of metal complex dyes | CIBA-GEIGY CORPORATION (US) | 1982-03-30 | — | — | US | disclosed |
| US-4248775-A | BY REACTING AN AZO-METHINE DYE BASE WITH A DIALKYL SULFATE | BAYER AKTIENGESELLSCHAFT (DE) | 1981-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559586-B2 | Compositions containing uretdione groups crosslinking at low temperatures | URB2, UQCRB, UQCRC2 | ALDH1A1 1357/4885LMNA 1319/4885L3MBTL1 3338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.